期刊
FEBS LETTERS
卷 586, 期 14, 页码 2003-2015出版社
WILEY
DOI: 10.1016/j.febslet.2012.05.027
关键词
Transforming growth factor beta; Extracellular matrix; Marfan syndrome; Stiff skin syndrome; Fibrillin; Integrin
资金
- Howard Hughes Medical Institute Funding Source: Medline
Transforming growth factor beta (TGF beta) is a multipotent cytokine that is sequestered in the extracellular matrix (ECM) through interactions with a number of ECM proteins. The ECM serves to concentrate latent TGF beta at sites of intended function, to influence the bioavailability and/or function of TGF beta activators, and perhaps to regulate the intrinsic performance of cell surface effectors of TGF beta signal propagation. The downstream consequences of TGF beta signaling cascades in turn provide feedback modulation of the ECM. This review covers recent examples of how genetic mutations in constituents of the ECM or TGF beta signaling cascade result in altered ECM homeostasis, cellular performance and ultimately disease, with an emphasis on emerging therapeutic strategies that seek to capitalize on this refined mechanistic understanding. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据